Last reviewed · How we verify

PH80

Pherin Pharmaceuticals, Inc. · Phase 3 active Small molecule

PH80 is a pheromone-based therapeutic designed to modulate human behavior and physiological responses through olfactory signaling.

PH80 is a pheromone-based therapeutic designed to modulate human behavior and physiological responses through olfactory signaling. Used for Social anxiety disorder, Autism spectrum disorder (social communication deficits).

At a glance

Generic namePH80
SponsorPherin Pharmaceuticals, Inc.
Drug classPheromone therapeutic
ModalitySmall molecule
Therapeutic areaPsychiatry / Behavioral Health
PhasePhase 3

Mechanism of action

PH80 contains synthetic human pheromones that are believed to influence social bonding, emotional state, and interpersonal attraction through the vomeronasal organ and olfactory system. The drug is intended to enhance social communication and reduce anxiety in social contexts by triggering subconscious neurochemical responses.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results